Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damage.

Cardiovascular research - 1 Sept 2012

Carnevale Daniela, Lembo Giuseppe

Abstract excerpt

In the past decade, several studies have characterized a number of cellular and molecular mechanisms that contribute to the regulation of the vascular myogenic response, thus affecting blood pressure regulation. Recently, phosphoinositide 3-kinase γ (PI3Kγ) has been identified as a main regulator of vascular myogenic tone and blood pressure, a result further strengthened by a highly significant genome-wide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Arterial Pressure
Share to Calcium Channels, L-Type

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Muscle, Smooth, Vascular

Share to Phosphatidylinositol 3-Kinase

Share to Phosphoinositide-3 Kinase Inhibitors

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 22610309
DOI: 10.1093/cvr/cvs166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damage.PMID 22610309Read ↗

Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.Semantic proximity Read ↗

Vascular smooth muscle contraction in hypertension.Semantic proximity Read ↗

Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?Semantic proximity Read ↗

Vascular Smooth Muscle as a Target for Novel Therapeutics.Semantic proximity Read ↗

Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.Semantic proximity Read ↗

Role of the Peroxisome Proliferator Activated Receptors in HypertensionSemantic proximity Read ↗

PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.Semantic proximity Read ↗

Lipid phosphate phosphatase 3 in vascular pathophysiology.Semantic proximity Read ↗

The biological impact of blood pressure-associated genetic variants in the natriuretic peptide receptor C gene on human vascular smooth muscle.Semantic proximity Read ↗

Serine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculature.Semantic proximity Read ↗

Role of sGC-dependent NO signalling and myocardial infarction risk.Semantic proximity Read ↗

The BK potassium channel in the vascular smooth muscle and kidney: α- and β-subunits.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.